Related Experiment Videos
[Continuous veno-venous hemofiltration in acute renal insufficiency]
1Division de Néphrologie, Hôpital Cantonal Universitaire de Genéve.
Nephrologie
|January 1, 1990
Summary
Continuous veno-venous hemodiafiltration (CVVHDF) effectively manages acute renal failure, showing significant reductions in creatinine and urea levels. This safe and reliable treatment ensures good fluid balance control in patients.
Area of Science:
- Nephrology
- Intensive Care Medicine
- Biomedical Engineering
Context:
- Acute renal failure (ARF) presents significant management challenges.
- Continuous renal replacement therapies (CRRT) are crucial for critically ill patients.
- Optimizing CRRT protocols is essential for patient outcomes.
Purpose:
- To evaluate the efficacy and safety of a fully pump-assisted continuous veno-venous hemodiafiltration (CVVHDF) system.
- To assess the impact of CVVHDF on biochemical parameters and fluid balance in ARF patients.
- To determine the reliability and tolerance of the CVVHDF system.
Summary:
- A study involving 10 ARF patients utilized a pump-assisted CVVHDF system with controlled flow rates and high dialysate recovery (97%).
- Mean serum creatinine and urea levels significantly decreased after 4-7 days of CVVHDF treatment.
- The system demonstrated efficient removal of glucose and phosphate, with minimal amino acid losses and stable hemodynamic parameters.
Impact:
- CVVHDF provides a safe, efficient, and reliable treatment option for acute renal failure.
- The system allows for effective control of fluid balance in critically ill patients.
- This modality shows minimal adverse effects on leukocyte, thrombocyte counts, and pO2 levels.